Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pancreatic beta cell replacement encompasses various therapeutic strategies aimed at restoring or replacing insulin-producing beta cells in patients with type 1 diabetes. These strategies include islet transplantation, whole pancreas transplantation, stem cell-derived beta cell therapy, xenotransplantation, and beta cell regeneration/neogenesis. The goal is to achieve insulin independence and restore normal glycemic control. Challenges include donor scarcity, immune rejection, and the need for long-term graft survival.
Restoration of insulin production by replacing or regenerating functional pancreatic beta cells.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pancreatic Beta Cell Replacement (β-cell Replacement).